Overview Quote
Stock Activity
| Day Low - High | 54.37 - 55.11 |
| 52wk Low - High | 35.98 - 56.91 |
| Previous Close | 54.65 |
| Avg. Volume | 2,602,832 |
| Industry | RETAIL-DRUG STR |
| Market Cap | 12.58 B |
| Div - Yield | 0.84 - 1.54 |
| Beta | 0.74 |
| PE (Forward) | 17.98 |
| Current Year Est. | 3.04 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
42 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Company Description
AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (09/2013) |
Next Year (09/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.75 | 0.73 | 3.04 | 3.65 |
| Number of Estimates | 8 | 7 | 1 | 9 |
| Low Estimate | 0.71 | 0.69 | 3.04 | 3.55 |
| High Estimate | 0.80 | 0.80 | 3.04 | NA |
| Year Ago EPS | 0.72 | 0.69 | 2.83 | 3.04 |
| EPS Growth | 4.17% | 6.00% | 7.42% | 20.10% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| AMERISOURCEBRGN | ABC | 54.65 | ![]() |
![]() |
| CHINA NEPSTAR | NPD | 1.71 | ![]() |
![]() |
| GNC HOLDINGS | GNC | 45.78 | ![]() |
![]() |
| HERBALIFE LTD | HLF | 50.54 | ![]() |
![]() |
| RITE AID CORP | RAD | 2.89 | ![]() |
![]() |
| CARDINAL HEALTH | CAH | 47.96 | ![]() |
![]() |
| CVS CAREMARK CP | CVS | 59.51 | ![]() |
![]() |
| MCKESSON CORP | MCK | 118.41 | ![]() |
![]() |
| PHARMERICA CORP | PMC | 14.19 | ![]() |
![]() |
| BIOSCRIP INC | BIOS | 13.68 | ![]() |
![]() |
Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR
Zacks Commentary
The Zacks Analyst Blog Highlights: Walgreen, AmerisourceBergen, CVS Caremark, Cardinal Health and R.R. Donnelley & Sons
May 21, 2013
Green Light for WAG and ABC Deal
May 20, 2013
Walgreens Reaches New 52-Week High
May 16, 2013
Walgreens-CVS Extend Pharmacy Deal
May 14, 2013
AmerisourceBergen Misses Estimates
Apr 25, 2013
Earnings Preview: AmerisourceBergen
Apr 24, 2013
Still Neutral on Walgreens
Apr 18, 2013
The Zacks Analyst Blog Highlights: AmerisourceBergen, Walgreens, Cardinal Health, CVS Caremark and Duke Energy
Apr 04, 2013
Financials
| EPS TTM | 2.95 |
| Sales | 79,490 |
| Net Income | 559 |
| Price/Earnings | 18.52 |
| Price/Book | 5.36 |
| Price/Cash Flow | 15.75 |
| Price/Sales | 0.15 |
News
AmerisourceBergen Has Returned 39.0% Since SmarTrend Recommendation (ABC) - Comtex Smartrend(R)
May 22, 2013
AmerisourceBergen (ABC) Approaches New Downside Target of $54.40 - Financial News Network Online - Pivot Alerts
May 21, 2013
AmerisourceBergen Garners Regulatory Approval of Walgreens and Alliance Boots Equity Investment - Close-Up Media
May 21, 2013
AmerisourceBergen Reports Approval of Walgreens and Alliance Boots Equity Stake - Close-Up Media
May 21, 2013
AmerisourceBergen Secures Regulatory Approval of Walgreens and Alliance Boots Equity Investment - Close-Up Media
May 21, 2013
AmerisourceBergen Wins Regulatory Approval of Walgreens and Alliance Boots Equity Investment - Close-Up Media
May 21, 2013
The Zacks Analyst Blog Highlights: Walgreen, AmerisourceBergen, CVS Caremark, Cardinal Health and R.R. Donnelley & Sons - Pr Newswire
May 21, 2013
Walgreens and Alliance Boots Acheive Regulatory Clearance to Make Equity Investment in AmerisourceBergen - Close-Up Media
May 21, 2013
Broker Recommendations
| Current ABR | 2.25 |
| ABR (Last Week) | 2.25 |
| # of recs in ABR | 8 |
| Average Target Price | 56.79 |
| Industry Rank by ABR | 42 out of 265 |
| Rank in Industry | 5 out of 11 |

